Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients.

Ten Berge, Daan; Muller, Wim; Beishuizen, Albertus; Cornet, Alexander Daniel; Slingerland, Robbert; Krabbe, Johannes

Ten Berge, Daan; Muller, Wim; Beishuizen, Albertus; Cornet, Alexander Daniel; Slingerland, Robbert; Krabbe, Johannes.

Ten Berge D; Department of Clinical Chemistry and Laboratory Medicine, Medlon BV, Enschede, The Netherlands.
Muller W; Department of Clinical Chemistry, Isala Clinics, Zwolle, The Netherlands.
Beishuizen A; Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands.
Cornet AD; Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands.
Slingerland R; Department of Clinical Chemistry, Isala Clinics, Zwolle, The Netherlands.
Krabbe J; Department of Clinical Chemistry and Laboratory Medicine, Medlon BV, Enschede, The Netherlands.

Clin Chem Lab Med ; 59(5): e197-e199, 2021 04 27.

Article in English | MEDLINE | ID: covidwho-1430563

Subject(s)

Ascorbic Acid/therapeutic use; Point-of-Care Systems; Blood Glucose; Critical Illness; Glucose; Humans; Vitamins

Keywords

blood glucose meters; critically ill patients; renal insufficiency; vitamin C interference

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ascorbic Acid / Point-of-Care Systems Limits: Humans Language: English Journal: Clin Chem Lab Med Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2021 Document Type: Article Affiliation country: Cclm-2020-1445

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google